Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) closed the most recent trading day at $238.11, moving -2.09% from the previous trading session. This change lagged the S&P 500's 0.25% gain on the day. Elsewhere, the Dow

Intel (INTC) Stock Sinks As Market Gains: Here's WhyPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Intel (INTC) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Intel (INTC) closed at $44.06, marking a -3.72% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.25% for the day. At the

NextNav Inc. (NN) Reports Q4 Loss, Beats Revenue Estimates
NextNav Inc. (NN) Reports Q4 Loss, Beats Revenue Estimates

NextNav Inc. (NN) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.2 per share a year ago. These

Titan America (TTAM) Q4 Earnings and Revenues Lag Estimates
Titan America (TTAM) Q4 Earnings and Revenues Lag Estimates

Titan America (TTAM) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.21 per share a year ago. These

Adient (ADNT) and Johnson Control International (JCI) Are Aggressive Growth Stocks
Adient (ADNT) and Johnson Control International (JCI) Are Aggressive Growth Stocks

As the aggressive growth stock strategist at Zacks Investment Research Brian Bolan usually looks for stocks that have a strong Zacks Style Score for Growth and a weak Zacks Style Score for Value

Lululemon (LULU) Tops Q4 Earnings and Revenue Estimates
Lululemon (LULU) Tops Q4 Earnings and Revenue Estimates

Lululemon (LULU) came out with quarterly earnings of $5.01 per share, beating the Zacks Consensus Estimate of $4.76 per share. This compares to earnings of $6.14 per share a year ago. These figures

Energy Vault Holdings, Inc. (NRGV) Reports Q4 Loss, Tops Revenue Estimates
Energy Vault Holdings, Inc. (NRGV) Reports Q4 Loss, Tops Revenue Estimates

Energy Vault Holdings, Inc. (NRGV) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.35 per share a year ago

DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates

DocuSign (DOCU) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.86 per share a year ago. These figures

HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates

HealthEquity (HQY) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.69 per share a year ago. These

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates
Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.15 per share a year ago. These figures are

Micron Continues to Display The Power of the Zacks RankPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Micron Continues to Display The Power of the Zacks Rank

Micron MU is a world leader in innovative memory and storage solutions that accelerate the transformation of information into intelligence. Shares have been red hot on the back of the AI frenzy

Top Stock Reports for GE Aerospace, Shell & McKessonPhoto, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
Top Stock Reports for GE Aerospace, Shell & McKesson

Tuesday, March 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including GE Aerospace

Howmet's Defense Aerospace Strength Seems Firm: More Upside Ahead?Photo, wide shot, wide-angle lens,  Conglomerate, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/95f18fed-a4d6-4069-b489-4d050c74c618.png
Howmet's Defense Aerospace Strength Seems Firm: More Upside Ahead?

Howmet Aerospace Inc. HWM is poised to gain from the expanding defense budget, which remains a key growth catalyst. In the fourth quarter of 2025, revenues from the defense aerospace market rose 20%

CSCO Taps NVIDIA to Drive Secure AI at the Edge: More Upside Ahead?Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
CSCO Taps NVIDIA to Drive Secure AI at the Edge: More Upside Ahead?

Cisco Systems CSCO is expanding its Secure AI Factory with NVIDIA Corporation (NVDA), which will enable enterprises to run AI everywhere instead of only in large data centers. The expanded solution

AIG Expands Specialty Reach With McGill Tie-Up, Targets $1.6B BookPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
AIG Expands Specialty Reach With McGill Tie-Up, Targets $1.6B Book

American International Group, Inc. AIG recently entered into a long-term strategic partnership with McGill and Partners. The goal is to modernize specialty insurance using data and digital tools

Best Value Stocks to Buy Now and How to Find Them
Best Value Stocks to Buy Now and How to Find Them

No one knows what’s right around the corner given the geopolitical turmoil. Still, stocks jumped slightly through morning trading on Tuesday after the Nasdaq and the S&P 500 charged higher to start

2 Top Performing Stocks to Watch as Earnings Approach: FIVE, MU
2 Top Performing Stocks to Watch as Earnings Approach: FIVE, MU

Set to release their quarterly reports after-market hours on Wednesday, March 18, Five Below FIVE and Micron Technology MU are two of the hottest stocks to consider at the moment. 

Providing quality

FEIM's Q3 Earnings Down Y/Y Due to Margin Pressure, Backlog Grows
FEIM's Q3 Earnings Down Y/Y Due to Margin Pressure, Backlog Grows

Shares of Frequency Electronics, Inc. FEIM have declined 11.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index, which fell 2.1% over

NU's Post-Earnings Dip Despite Strong Results: A Buying Opportunity?
NU's Post-Earnings Dip Despite Strong Results: A Buying Opportunity?

Sometimes it helps to step back after results are out and let the market digest the numbers before concluding. Following its late-February earnings release, Nu Holdings NU saw its stock slide

Tredegar's Q4 Earnings Soar Y/Y on Aluminum Extrusions Strength
Tredegar's Q4 Earnings Soar Y/Y on Aluminum Extrusions Strength

Shares of Tredegar Corporation TG have underperformed the broader market following the release of its fourth-quarter results. The stock has declined 3.4% since the earnings announcement for the

Best Momentum Stocks on the Zacks Rank (CIEN, MU, CENX)
Best Momentum Stocks on the Zacks Rank (CIEN, MU, CENX)

There is always a bull market somewhere.

Despite shifting headlines and constantly evolving market narratives, certain stocks and sectors continue to benefit from prevailing economic regimes. In the

RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?Photo, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?

Reinsurance Group of America RGA is a leading global provider of traditional life and health reinsurance, as well as financial solutions, with operations across the United States, Latin America

KROS: Is the Discount Book Value a Value Trap?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
KROS: Is the Discount Book Value a Value Trap?

Keros Therapeutics KROS posted a dramatic revenue jump in 2025, but the mix matters as much as the magnitude. The shares also trade at a steep discount to book value, creating the classic biotech

KROS Stock: What to Know About Rinvatercept in DMD
KROS Stock: What to Know About Rinvatercept in DMD

Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program